[1]
“ESTIMATION OF THE EFFECTIVENESS OF FINANCIAL COSTS FOR TARGETED THERAPY OF PATIENTS WITH METASTATIC KIDNEY CANCER”, Вопр. онкол., vol. 64, no. 5, pp. 657–663, May 2018, doi: 10.37469/0507-3758-2018-64-5-657-663.